Edgewise Therapeutics (EWTX) Insider Trading & Ownership → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free EWTX Stock Alerts $16.11 +0.46 (+2.94%) (As of 04/24/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Edgewise Therapeutics (NASDAQ:EWTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage31.95%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$5.10 MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$3.83 M Get EWTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Edgewise Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EWTX Insider Buying and Selling by Quarter Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report Edgewise Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/9/2024John R. MooreGeneral CounselSell8,029$20.01$160,660.29 2/8/2024Behrad DerakhshanInsiderSell4,600$20.01$92,046.00 2/7/2024John R. MooreGeneral CounselSell17,993$20.00$359,860.00 1/23/2024Peter A ThompsonDirectorBuy454,545$11.00$4,999,995.00 1/23/2024R Michael CarruthersCFOSell90,000$15.78$1,420,200.00 12/27/2023John R. MooreGeneral CounselSell8,497$10.50$89,218.50 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/26/2023Alan J RussellInsiderSell172,585$9.33$1,610,218.05 12/26/2023Jonathan C FoxDirectorBuy10,857$9.30$100,970.10 5/2/2023Behrad DerakhshanInsiderSell1,747$8.90$15,548.30 5/2/2023Joanne M DonovanCMOSell3,254$8.90$28,960.60 5/2/2023John R MooreGeneral CounselSell1,897$8.90$16,883.30 5/2/2023Kevin KochCEOSell3,203$8.90$28,506.70 5/2/2023R Michael CarruthersCFOSell1,336$8.90$11,890.40 (Data available from 1/1/2013 forward) EWTX Insider Trading Activity - Frequently Asked Questions Who is on Edgewise Therapeutics's Insider Roster? The list of insiders at Edgewise Therapeutics includes Alan J Russell, Behrad Derakhshan, Holdings A/S Novo, Joanne M Donovan, John R Moore, Jonathan C Fox, Kevin Koch, Orbimed Advisors Llc, Peter A Thompson, and R Michael Carruthers. Learn more on insiders at EWTX. What percentage of Edgewise Therapeutics stock is owned by insiders? 31.95% of Edgewise Therapeutics stock is owned by insiders. Learn more on EWTX's insider holdings. Which Edgewise Therapeutics insiders have been buying company stock? The following insiders have purchased EWTX shares in the last 24 months: Holdings A/S Novo ($4,999,998.72), Jonathan C Fox ($100,970.10), Orbimed Advisors Llc ($994,980.00), and Peter A Thompson ($9,999,993.72). How much insider buying is happening at Edgewise Therapeutics? Insiders have purchased a total of 1,572,394 EWTX shares in the last 24 months for a total of $16,095,942.54 bought. Which Edgewise Therapeutics insiders have been selling company stock? The following insiders have sold EWTX shares in the last 24 months: Alan J Russell ($1,610,218.05), Behrad Derakhshan ($107,594.30), Joanne M Donovan ($28,960.60), John R Moore ($947,407.82), Kevin Koch ($28,506.70), and R Michael Carruthers ($1,432,090.40). How much insider selling is happening at Edgewise Therapeutics? Insiders have sold a total of 443,400 Edgewise Therapeutics shares in the last 24 months for a total of $4,764,516.66 sold. More Insider Trading Tools from MarketBeat Related Companies: ARDX Insider Ownership PTGX Insider Ownership DVAX Insider Ownership SUPN Insider Ownership AGIO Insider Ownership AVDL Insider Ownership RCUS Insider Ownership ZLAB Insider Ownership AMRX Insider Ownership KURA Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:EWTX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edgewise Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
